CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award See Remarks acquired 49,182 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 17,778 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 6,248 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 5,982 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 8,842 shares (to pay taxes)
- 4 Grant or award Director acquired 2,565 shares (grant or award)
- 4 Grant or award Director acquired 2,565 shares (grant or award)
- 4 Grant or award Director acquired 2,565 shares (grant or award)
- 4 Grant or award Director acquired 2,565 shares (grant or award)
- 4 Shares withheld for taxes SVP and CFO gave up 214 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 690 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 224 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 247 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 6,575 shares at $4.77 ($31,375)
- 4 Open-market sale Director sold 8,425 shares at an average $4.61 ($38,829)
- 4 Grant or award Director acquired 1,650 shares (grant or award)
Page 7 of 33 · 648 filings